Clinical Trial Update: The Study of Long-term Outcomes of GR1802 in Patients With Chronic Rhinosinusitis With Nasal Polyps [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for GR1802 in chronic rhinosinusitis with nasal polyps (CRSwNP).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rhinosinusitis with Nasal Polyps

Drugs mentioned

• GR1802 (GR1802)

Snippet

Sponsor: Genrix (Shanghai) Biopharmaceutical Co., Ltd. | Conditions: Chronic Rhinosinusitis With Nasal Polyps | Phase 2 | Status: UNKNOWN